📣 Exciting news! Thrilled to share that I have started at @MDAndersonNews as an Assistant Professor of Radiation Oncology ☢️, specializing in tumors of the brain and spine 🧠
Grateful for this opportunity to make a meaningful impact in patients' lives 🙏
Still feels unreal! I am so excited to have matched to @MDAndersonNews for #radonc ! What a journey it’s been to get here! I am so thankful for my incredible wife, my loving family, and all my amazing mentors that invested in me to help make this dream possible!
BREAKING NEWS
The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.
Fascinating presentation from #radonc resident @MDAndersonNews@adam_grippin, travel award winner to #WCLC2023, on temporal relationship of PD-L1 induction and #CovidVaccines in lung cancer diagnostic biopsies. Therapeutic implication being explored!
A prospective study by @MartinTomMD and colleagues showed that PET/CT with 18F-fluciclovine, a repurposed widely available radiotracer, has promising ability to distinguish radiation necrosis from tumor progression after #radiosurgery.
Read more: https://t.co/6TDJK4VmWq
Stellar @baylormed MS3 Marcus Flores presents on how the PRISM score stratifies outcomes for patients treated with SSRS @MDAndersonNews and Mayo. Important implications to individualize treatment for patients! Thanks for excellent mentorship @BrianDeMD!
Excited to share our work on the incidence of PEP changes in phase 3 clinical trials. I'm grateful for the opportunity to work on such an impactful project under the mentorship of @ebludmir and @JAbiJaoude. Thnx to the support of our team @MDAndersonNews https://t.co/Pr0BlV3xB7
Men with cT4 prostate ca have significant morbidity associated w/ local disease burden.
Definitive local therapy with☢️ or🔪 was associated w/ 📈 LRFS, DFS, CRFS, and OS, even in men with M1 disease!
https://t.co/erZi0idYNY
There has been a lot of 🔥discussion lately of short course radiation (SCRT) for locally advanced rectal cancer (LARC).
I❤️SCRT bc it is convenient for working patients or those who travel for 🏥care. However, the RAPIDO update gives me pause. Let’s look at the history of SCRT:
Marion U. Schwartz Memorial Research Fellowship: Supported by CCF.
Ethan Ludmir, The University of Texas MD Anderson Cancer Center
Integrating Radiomics and Immunogenomics to Predict Tumor-Related Liver Failure for Patients with Metastatic Intrahepatic Cholangiocarcinoma.
Kids asleep,🧵time: EXTEND is randomized basket trial testing whether MDT improves PFS for oligometastatic cancers. The primary analysis for each histology-specific basket. Thanks to @JAMAOnc for reporting the prostate intermittent hormone basket here: https://t.co/XEKXqRee5D
@ggreen1986 Great question. Our practice has been to give LCT as true consolidation for OM-NSCLC, i.e., after upfront osi, to lesions that are visible on CT except sclerotic mets that are no longer FDG avid on PET. This may change in the coming yrs as the data evolve.
Pleased to share our work in JCO Precision Oncology examining molecular alterations among NSCLC patients with synchronous oligometastatic disease in this collaborative work from @MDAndersonNews, available as open access.
https://t.co/i1aVu5D8cp
Packed house for the Ritsuko and James Cox Lectureship!Thank you @_APollack for your Grand Rounds lecture & for spending the day with our residents.This is a beautiful way to honor a giant in our field who was tirelessly committed to education. We miss him so much. @ACKoongMDPhD
Delighted to share our most recent work investigating #aging after #WBRT, published in Neuro-0ncology @NeuroOnc. Free access link: https://t.co/KnIluyQJzc
We introduce #DeepGlioma, the first AI-based molecular classification system for diffuse gliomas. DeepGlioma was developed by @mlins_lab at @umichneuro with our incredible collaborators. Check out the paper in @NatureMedicine at https://t.co/dYGmuvjtYF.
Had a great dinner tonight celebrating the achievements of these outstanding humans! So proud they are directing some of their interest & talents to projects studying late toxicity & patient reported outcomes for folks w/ anal & rectal cancers! #HollidayNonLab@MDAndersonNews